BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.

Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.

What Are We Doing?

Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies.

We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.

Who is BlueRock?

BlueRock Therapeutics LP is a clinical stage cell therapy company harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.

What Are We Doing?

Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.

We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.

Description Of Position

The Senior Vice President, Cell Therapy Product Supply Operations is a key enterprise leader responsible for building, scaling, and integrating the end-to-end technical operations network for an allogeneic, iPSC-derived cell therapy portfolio from preclinical development through Phase III clinical supply and launch readiness. This role oversees the strategy, execution, and continuous improvement of Supply Chain, Manufacturing, MS&T (Manufacturing Science & Technology), and External Manufacturing across both cell product supply and associated device supply.

The SVP will ensure a robust, phase-appropriate, scalable, and inspection-ready operating model that supports internal manufacturing in Toronto, Canada and external partners, such as Bayer Pharma in Berkeley, CA, for early-stage clinical and non-clinical supply. This includes strategic oversight of contract and partner operations such as Bayer Pharma in Berkeley, California, and other current or future partners.

This executive will partner cross-functionally with CMC, Process Development, Analytical, Quality, Regulatory, Clinical Operations, Program Leadership, Finance, and Commercial/Launch Planning to ensure reliable supply, effective technology transfer, strong operational governance, and readiness for product launch.

Responsibilities

• Lead enterprise Product Supply operations strategy across development stages
• Oversee internal manufacturing operations in Toronto for early-stage clinical supply
• Lead MS&T including tech transfer, process robustness, and lifecycle management
• Own end-to-end supply chain strategy including planning, sourcing, and logistics
• Oversee external manufacturing network for Phase I to Phase III
• Manage external device manufacturing strategy and supplier governance
• Drive successful technology transfer and site readiness
• Enable launch readiness including supply, inventory, and network preparedness
• Partner with Quality to ensure GMP compliance and inspection readiness
• Build and lead a high-performing Product Supply organization
• Partner with the SVP of Technical Development Strategy to establish a scalable roadmap for transitioning from early-stage/internal supply to late-stage/externalized supply while preserving comparability, compliance, reliability, and cost discipline

Minimum Requirements

• 15+ years of biotech/pharma operations experience
• Executive leadership across manufacturing, supply chain, MS&T, and external manufacturing
• Experience supporting late-stage clinical programs and launch readiness
• Strong knowledge of GMP, regulatory expectations, and partner oversight
• Preferred: experience with allogeneic/iPSC-derived cell therapy and device supply
• Critical Leadership Capabilities
• Strategic and enterprise-minded
• Strong operator with rigorous execution discipline
• Deep technical credibility in advanced therapies
• Effective in ambiguity and rapid-growth environments
• Skilled in external partner governance and executive influence
• Data-driven, risk-aware, and solutions-oriented
• Strong people leader and organizational builder

Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

The estimated compensation range for this position is $ 318,000.00 - $ 337,500.00 per year.

Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.